Background: A subset of patients with Peyronie's disease (PD) treated with collagenase clostridium histolyticum (CCH) experience persistent bother and some require surgery.
Aim: We characterize patients experiencing persistent bother after CCH treatment and identify associations and predictors of surgical intervention/outcomes.
Methods: We retrospectively identified patients with PD from October 2014 to October 2019 and identified those presenting with persistent bother after CCH treatment by other urologists.
OBJECTIVEThe Patient-Reported Outcomes Measurement Information System (PROMIS) was developed to provide a standardized measure of clinical outcomes that is valid and reliable across a variety of patient populations. PROMIS has exhibited strong correlations with many legacy patient-reported outcome (PRO) measures. However, it is unclear to what extent PROMIS has been used within the spine literature.
View Article and Find Full Text PDFStudy Design: This is a retrospective cohort study.
Objective: To determine the association between preoperative medications and length of stay, inpatient pain, and narcotics consumption after a minimally invasive transforaminal lumbar interbody fusion (MIS TLIF).
Summary Of Background Data: Previous studies have identified risk factors for increased length of hospital stay, inpatient pain, and narcotics consumption.
Background: Total hip arthroplasty (THA) is projected to increase in prevalence and associated complications will impose significant cost on the US healthcare system. The purpose of this study is to validate a predictive model for postoperative complications utilizing a novel 11-component hip-specific questionnaire encompassing preoperatively available clinical and radiographic data.
Methods: Consecutive primary THA patients between January 2014 and January 2016 were included.